Clinical Trial Update: AVIDA The Vidaza® (Azacitidine) Patient Registry

View source ↗

Summary

This update concerns the AVIDA Vidaza (azacitidine) patient registry for myelodysplastic syndromes, noting that the registry study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Celgene | Conditions: Myelodysplastic Syndromes | Status: COMPLETED